LS Cozma, SD Luzio, GJ Dunseath, KW … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—All three drugs were equally effective on the total prandial insulin
secretion (area under the curve [AUC] −15 to 240 min). However, clear
differences were noted in the early insulin secretion (AUC −15 to 30 ... Cited by 37 - Related articles - BL Direct - All 8 versions
S Madsbad, B Kilhovd, I Lager, P Mustajoki, A … - Diabetic Medicine, 2001 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 29 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org MF Carroll, A Izard, K Riboni, MR Burge, DS … - Diabetes Care, 2002 - Am Diabetes Assoc RESULTS—The subjects were aged 56 ± 2 years and were moderately obese (BMI 31
± 1 kg/m 2 ), with a mean HbA 1c of 7.4 ± 0.4%. The peak postprandial glucose
excursion above baseline was higher with placebo (6.1 ± 0.5 mmol/l) than ... Cited by 30 - Related articles - BL Direct - All 6 versions
PD Home - Experimental and clinical endocrinology & diabetes: …, 1999 - ncbi.nlm.nih.gov The history of achieving adequate insulin secretion in Type 2 diabetes has
interesting parallels with Type 1 diabetes. Initial insulin secretagogue therapy
involved short-acting sulphonylureas--tolbutamide being introduced 40 years ... Cited by 24 - Related articles - BL Direct - All 3 versions
MR Rizzo, M Barbieri, R Grella, N Passariello … - Diabetes and Metabolism, 2004 - Elsevier Both R and G significantly but similarly lowered fasting glucose levels and
improved fasting plasma insulin levels vs baseline. Hyperglycemic clamp showed
that both 1 st (129.15 ± 23.6 vs 106.90 ± 18.6 pmol/L; p = 0.01) and 2 nd ... Cited by 13 - Related articles - BL Direct - All 3 versions
AH Barnett, DM Anderson, S Shelley, R … - Diabetes Obesity and Metabolism, 2004 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►endojournals.org W Aldhahi, J Armstrong, C Bouche, RD Carr, … - Journal of Clinical Endocrinology & Metabolism, 2004 - Endocrine Soc Oral hypoglycemic agents bind to the ATP-sensitive potassium channel and lower
glucose levels effectively in individuals with diabetes. Although the principle
mechanism of action can also promote hypoglycemia, clinically profound ... Cited by 4 - Related articles - BL Direct - All 4 versions
LS Cozma, SD Luzio, GJ Dunseath, PM … - Diabetes care, 2005 - Am Diabetes Assoc RESULTS—The insulinogenic index (ΔI30/ΔG30) and insulin area under the curve
(AUC) from 0 to 30 min (AUC 0–30 ) were higher with the 4-mg drug dose
compared with the two lower doses and with 2 mg compared with 0.5 mg. On ... Cited by 7 - Related articles - All 5 versions
